The longer answer requires understanding why GLP-1 receptor agonists raise pharmacokinetic questions for any concomitant oral drug, and why PPIs specifically are low-risk in this pairing
Dougados M, Wei JC, Landewe R et al (2020) Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W)
Though Rossi recommends L
Anyone starting semaglutide, especially those with a history of low blood pressure or using diuretics, may need extra attention
GLP-1 receptors exist in areas of the brain where drugs and alcohol are believed to cause pleasure
However, local concentration gradients may favor tissues nearest the injection point, at least initially after administration